JenaValve is in the process of obtaining FDA approval for the first transcatheter aortic valve to address aortic ...

The U.S. Federal Trade Commission has sued to block Edwards Lifesciences Corp's acquisition of JenaValve Technology Inc, ...

FTC sues to block Edwards Lifesciences' $1.2B JenaValve deal. Edwards disputes, revises 2025 EPS guidance, and pursues ...

Edwards Lifesciences announced that the U.S. Federal Trade Commission (FTC) seeks to block its planned $1.2 billion ...

Edwards Lifesciences and JenaValve said they remained committed to completing the deal and would defend the case in court.

Edwards Lifesciences (NYSE: EW) announced today that the U.S. Federal Trade Commission (FTC) moved to block the company’s proposed acquisition of JenaValve Technology.

Detailed price information for Edwards Lifesciences Corp (EW-N) from The Globe and Mail including charting and trades.

The Federal Trade Commission has moved to block Edwards Lifesciences' proposed acquisition of medical-device company JenaValve Technology. The FTC said in a complaint filed Wednesday the acquisition ...

Investing.com -- Moody’s Ratings has affirmed Edwards Lifesciences Corporation ’s Baa2 ratings while revising the outlook to positive from stable, the credit rating agency announced Wednesday.

A year ago, three firms were racing to bring transcatheter aortic valve replacement devices to market. The FTC said allowing ...

Detailed price information for Edwards Lifesciences Corp (EW-N) from The Globe and Mail including charting and trades.